Screener
Jade Biosciences JBIO JADE101 — Research And Development Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Jade Biosciences in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| JADE101 external research and development costs | $15,423 | $9,767 |
| JADE201 external research and development costs | 2,877 | 5,154 |
| JADE301 external research and development costs | 5,922 | 733 |
| Research and development personnel-related costs (including stock-based compensation) | 10,648 | 3,952 |
| Other research and development costs | 1,183 | 417 |
| General and administrative personnel-related costs (including stock-based compensation) | 5,298 | 1,713 |
| General and administrative professional, consulting, and other fees | 2,094 | 1,648 |
Item 1. Financial Statements.
FAQ
- What is Jade Biosciences's JADE101 — research and development expense?
- Jade Biosciences (JBIO) reported JADE101 — research and development expense of $15.42M in Q1 2026.
- How has Jade Biosciences's JADE101 — research and development expense changed year-over-year?
- Jade Biosciences's JADE101 — research and development expense increased by 57.9% year-over-year, from $9.77M to $15.42M.
- What does JADE101 — research and development expense mean?
- This metric represents the total operating costs incurred by the JADE101 segment to advance its pipeline of therapeutic candidates through preclinical and clinical development stages. It captures expenditures related to drug discovery, laboratory research, and the regulatory activities required to support investigational new drug applications. Monitoring this expense provides insight into the company's commitment to innovation and the capital intensity required to bring its specific autoimmune disease therapies to market.
Ask your AI about Jade Biosciences's jade101 — research and development expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude